Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

Similar presentations


Presentation on theme: "Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing."— Presentation transcript:

1 Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study  Georg Griesinger, M.D., M.Sc., Ph.D., Laura Schultz, Thomas Bauer, M.D., Anke Broessner, M.D., Thorsten Frambach, M.D., Stefan Kissler, M.D., Ph.D.  Fertility and Sterility  Volume 95, Issue 6, Pages e1 (May 2011) DOI: /j.fertnstert Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Cumulative rate of live birth per patient stratified for the number of oocytes retrieved after GnRH agonist triggering. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

3 Figure 2 Cumulative rate of a positive hCG test leading to a live birth. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing."

Similar presentations


Ads by Google